Back
CLP Holdings Ltd. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
50
CLPHY
CLP Holdings Ltd.
Last Price:
$8.93
Seasonality Move:
1.16%
Sell
23
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$32.80
Seasonality Move:
-0.96%
Sell
50
CLP Holdings Ltd. (CLPHY)
is a Sell
Is CLP Holdings Ltd. a Buy, Sell or Hold?
-
The current CLP Holdings Ltd. [CLPHY] share price is $8.85. The Score for CLPHY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
CLPHY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.21. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLPHY Stock Price Chart
What is CLP Holdings Ltd.'s stock price today?
-
The CLP Holdings Ltd. share price today is $8.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLPHY is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $33.21Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
CLPHY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 53.26 | Buy |
| Chaikin Money Flow: | -56521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.75 - 8.93) | Buy |
| Bollinger Bands (100): | (8.32 - 8.76) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.65 | Buy |
| Relative Strength Index (14 RSI): | 43.13 | Sell |
| Chaikin Money Flow: | -1062961 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 35.95) | Sell |
| Bollinger Bands (100): | (29.01 - 34.13) | Buy |
CLPHY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.78 | Buy |
| 20-day SMA: | 8.82 | Buy |
| 50-day SMA: | 8.69 | Buy |
| 200-day SMA: | 8.45 | Buy |
| 8-day EMA: | 8.82 | Buy |
| 20-day EMA: | 8.8 | Buy |
| 50-day EMA: | 8.71 | Buy |
| 200-day EMA: | 8.51 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.62 | Sell |
| 20-day SMA: | 34.63 | Sell |
| 50-day SMA: | 33.66 | Sell |
| 200-day SMA: | 33.65 | Sell |
| 8-day EMA: | 7.38 | Buy |
| 20-day EMA: | 3.16 | Buy |
| 50-day EMA: | 1.3 | Buy |
| 200-day EMA: | 0.33 | Buy |
CLP Holdings Ltd. Earnings Growth & CLPHY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
CLP Holdings Ltd. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||